Hemoptysis in a referral hospital for pulmonology

Cavalcanti Lundgren, Fernando Luiz; Costa, Ana Maria; Caldas Figueiredo, LĂ­cia; Colares Borba, Paola
May 2010
Jornal Brasileiro de Pneumologia;may2010, Vol. 36 Issue 3, p320
Academic Journal
Objective: To determine the main causes of hemoptysis and to classify this symptom, in terms of the amount of blood expectorated, in patients hospitalized at a referral hospital for pulmonology. Methods: The study included 50 patients with hemoptysis admitted to the pulmonology ward of a general hospital in the city of Recife, Brazil, between July of 2005 and February of 2006. The data of interest were analyzed and compared with those in the literature. Results: The most common cause of hemoptysis was infection--in 39 patients (78%)--mostly related to tuberculosis sequelae or active tuberculosis. Regarding the severity of hemoptysis, moderate hemoptysis, diagnosed in 28 patients (56%), was the most common. Conclusions: Our results suggest that all patients who present with hemoptysis should be investigated for infection.


Related Articles

  • Comorbidities among HIV-infected injection drug users in Chennai, India. Solomon, S. S.; Hawcroft, C. S.; Narasimhan, P.; Subbaraman, R.; Srikrishnan, A. K.; Cecelia, A. J.; Kumar, M. Suresh; Solomon, Suniti; Gallant, J. E.; Celentano, D. D. // Indian Journal of Medical Research;May2008, Vol. 127 Issue 5, p447 

    Background & objectives: HIV-infected injection drugs users (IDUs) are known to have high rates of co-infections. A few reports exist on comorbidities among HIV-infected IDUs in India. We carried out a retrospective study to analyse data on comorbidities in India and treatment challenges faced...

  • News feature: A clash of cultures. Mandavilli, Apoorva // Nature Medicine;Mar2007, Vol. 13 Issue 3, p268 

    HIV and tuberculosis are a deadly combination, ravaging populations in Africa and Asia. But the two disease camps are too busy fighting each other to heed the crisis, says Apoorva Mandavilli.

  • Tuberculosis treatment default among TB-HIV co-infected patients in Nigeria. Ukwaja, Kingsley N. // Annals of Tropical Medicine & Public Health;May/Jun2013, Vol. 6 Issue 3, p382 

    A letter to the editor is presented on a study related to tuberculosis treatment default among HIV infected patients in Nigeria.

  • Risk of Complications in HIV-TB Co-Infection: A Hospital-Based Pair-Matched Case-Control Study. Harsha, Kumar H. N.; Gupta, Raghav // Indian Journal of Community Medicine;Oct2010, Vol. 35 Issue 4, p506 

    The article discusses a study which investigated the risk of complications in patients with co-morbid HIV and tuberculosis (TB) in South India. Study subjects were categorized according to age, sex and other confounding factors such as smoking, alcoholism, diabetes mellitus and hypertension....

  • Melioidosis and pulmonary tuberculosis co-infection in a diabetic. Shetty, Anup Kumar; Boloor, Rekha; Sharma, Vishnu; Keshava Bhat, Ganesh Hosahithlu // Annals of Thoracic Medicine;Apr-Jun2010, Vol. 5 Issue 2, p113 

    Burkholderia pseudomallei is the causative agent of melioidosis. It is endemic in South East Asian countries and North Australia. Sporadic cases of melioidosis have been reported from several parts of South India. Melioidosis may manifest as chronic pneumonia mimicking tuberculosis and generally...

  • Pay attention to drug interactions to ensure successful treatment of tuberculosis and HIV co-infection.  // Drugs & Therapy Perspectives;Aug2007, Vol. 23 Issue 8, p16 

    The article discusses a variety of issues concerning the treatment regimen for tuberculosis (TB) and HIV co-infection. Drug interactions should be considered when developing a treatment regimen for a patient with TB and HIV comorbidity. According to the author, effective antitubercular and...

  • Immunoendocrine Interactions during HIV-TB Coinfection: Implications for the Design of New Adjuvant Therapies. Suarez, Guadalupe Veronica; Vecchione, Maria Belen; Angerami, Matias Tomas; Sued, Omar; Bruttomesso, Andrea Claudia; Bottasso, Oscar Adelmo; Quiroga, Maria Florencia // BioMed Research International;5/14/2015, Vol. 2015, p1 

    Worldwide, around 14 million individuals are coinfected with both tuberculosis (TB) and human immunodeficiency virus (HIV). In coinfected individuals, both pathogens weaken immunological system synergistically through mechanisms that are not fully understood. During both HIV and TB infections,...

  • Abstract Supplement: HIV Drug Therapy in the Americas 8-10 May 2014, Rio de Janeiro, Brazil.  // Journal of the International AIDS Society;2014 Supplement 1, Vol. 17 Issue Supp 1, preceding p1 

    The article presents abstracts of articles on HIV drug therapy topics including "HIV policy in Central America," by Sosa Nestor, "Co-morbidities and ageing in HIV," by Reiss Peter, and "TB prevention and care," by Sued Omar.

  • TB/HIV co-infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: a 4 years retrospective study. Mekonnen, Daniel; Derbie, Awoke; Desalegn, Endalkachew // BMC Research Notes;11/11/2015, Vol. 8, p1 

    Background: Human immunodeficiency virus (HIV) and tuberculosis (TB) are the leading independent global causes of death among patients with infectious diseases. Additionally, due to the shared immune defense mechanisms, they are the leading cause of co-morbidities globally. However, little...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics